COMMUNIQUÉS West-GlobeNewswire

-
Transactions under Novozymes’ stock buyback program
02/07/2018 -
BrightGuard Installs Free Sunscreen Dispensers at New York City Public Pools and Beaches
02/07/2018 -
RedHill Biopharma Announces Allowance of Two New RHB-104 Patents Ahead of Top-Line Phase III Results for Crohn’s Disease
02/07/2018 -
Athenex Announces Pipeline Expansion Initiatives in Conjunction with a Strategic Investment of $100 million by Perceptive Advisors
02/07/2018 -
PotNetwork Holdings, Inc. Changing Name To Biotech Hemp, Inc. and Moves Forward on Filings In Preparation for Uplisting
02/07/2018 -
Mesoblast Enters Into US$50M Financing with Novaquest Capital for Commercial Readiness of Remestemcel-l in the Treatment of Acute Graft Versus Host Disease
02/07/2018 -
Arrayit Corporation Completes Allergy Testing Pilot Program for One of the Nation’s Largest Retail Chains
02/07/2018 -
Opthea’s Phase 2b Wet AMD Clinical Trial Reaches Mid-Way Point of Patient Recruitment
02/07/2018 -
FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants
02/07/2018 -
Dr. Deborah Dunsire named new President and CEO of Lundbeck
02/07/2018 -
Solon Eiendom ASA : Sales in Q2 2018
02/07/2018 -
Dr. Deborah Dunsire named new President and CEO of Lundbeck
02/07/2018 -
Solon Eiendom ASA : Primary insider notification
02/07/2018 -
NOTICE OF BIOHIT OYJ’S EXTRAORDINARY GENERAL MEETING
02/07/2018 -
Shire plc: Director/PDMR Shareholding
02/07/2018 -
Shire plc : Form 8 (DD) - Albert Stroucken
02/07/2018 -
Shire plc : Form 8 (DD) - Gail Fosler
02/07/2018 -
Shire plc : Form 8 (DD) - Steven Gillis
02/07/2018 -
Shire plc : Form 8 (DD) - David Ginsburg
02/07/2018
Pages